EVALUATION OF THE POTENTIAL FOR STEADY-STATE PHARMACOKINETIC INTERACTION BETWEEN ATORVASTATIN AND ASPIRIN IN HEALTHY SUBJECTS.

被引：0
|
作者：
Cho, H. [1 ]
Cho, D. [1 ]
Yeo, C. [1 ]
Bae, S. [1 ]
Shon, J. [1 ]
Park, S. [1 ]
Kim, E. [1 ]
Shin, J. [1 ]
机构：
[1] Inje Univ, Busan Paik Hosp, Pusan, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [31] LACK OF A PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN DIMEBON (LATREPIRDINE) AND WARFARIN IN HEALTHY SUBJECTS.
    Plowchalk, D. R.
    Qiu, R.
    Terra, S. G.
    Corrigan, B.
    Fang, J.
    Fullerton, T.
    Liu, J.
    Byon, W.
    Mordenti, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S57 - S57
  • [32] Investigation of Potential Pharmacokinetic Interactions Between Teneligliptin and Metformin in Steady-state Conditions in Healthy Adults
    Nakamaru, Yoshinobu
    Hayashi, Yoshiharu
    Davies, Martin
    Heuer, Horst Juergen
    Hisanaga, Noriko
    Akimoto, Kei
    CLINICAL THERAPEUTICS, 2015, 37 (09) : 2007 - 2018
  • [33] Steady-state pharmacokinetic interaction study of zonisamide (zonegran) and phenytoin in subjects with epilepsy
    Garnett, WR
    Towne, AR
    Rosenfeld, WE
    Shah, J
    Floren, LC
    Gross, J
    Tupper, R
    Shellenberger, K
    NEUROLOGY, 2001, 56 (08) : A336 - A336
  • [34] STEADY-STATE INTERACTION BETWEEN AMIODARONE AND PHENYTOIN IN NORMAL SUBJECTS
    NOLAN, PE
    ERSTAD, BL
    HOYER, GL
    BLISS, M
    GEAR, K
    MARCUS, FI
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (18): : 1252 - 1257
  • [35] LACK OF A CLINICALLY MEANINGFUL PHARMACOKINETIC INTERACTION BETWEEN ERTUGLIFLOZIN AND GLIMEPIRIDE OR SIMVASTATIN IN HEALTHY SUBJECTS.
    Sahasrabudhe, V.
    Kumar, V.
    Matschke, K.
    Shi, H.
    Alvey, C.
    Liang, Y.
    Fountaine, R. J.
    Hickman, A.
    Saur, D.
    Terra, S. G.
    Zhou, S.
    Cutler, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S46 - S47
  • [36] In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects
    Shoaf, Susan E.
    Ohzone, Yoshihiro
    Ninomiya, Shin-ichi
    Furukawa, Masayuki
    Bricmont, Patricia
    Kashiyama, Eiji
    Mallikaarjun, Suresh
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 761 - 769
  • [37] PHARMACOKINETIC INTERACTION OF BEPRIDIL AND DIGOXIN AT STEADY-STATE
    DOOSE, DR
    WALLEN, S
    NAYAK, RK
    MINN, FL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 204 - 204
  • [38] Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects
    Sunkara, Gangadhar
    Reynolds, Christine V.
    Pommier, Francoise
    Humbert, Henri
    Yeh, ChingMing
    Prasad, Pratapa
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (03) : 631 - 640
  • [39] PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN THE ANTIDEPRESSANT TIANEPTINE AND OXAZEPAM AT STEADY-STATE
    TOON, S
    HOLT, BL
    LANGLEY, SJ
    MULLINS, FGP
    ROWLAND, M
    HALLIDAY, MS
    SALVADORI, C
    DELALLEAU, B
    PSYCHOPHARMACOLOGY, 1990, 101 (02) : 226 - 232
  • [40] Steady-state pharmacokinetic properties of pramipexole in healthy volunteers
    Wright, CE
    Sisson, TL
    Ichhpurani, AK
    Peters, GR
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (06): : 520 - 525
12345